Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

International Bancshares Q4 Profit Down - Quick Facts

International Bancshares Corp. (IBOC: Quote) posted fourth-quarter net income applicable to common shareholders of $27.0 million, compared to $27.1 million in the comparable quarter last year. Earnings per share for the quarter was $0.40, same as last year.

Net income for fiscal 2011 applicable to common shareholders was $113.9 million, or $1.69 per share, down from $116.9 million or $1.72 per share in the prior year period.

Net interest income for fiscal 2011 was $324 thousand, compared to $345 thousand in the year-ago period, while non-interest income dropped to $201 thousand from $219 thousand last year.

Click here to receive FREE breaking news email alerts for INTL BANCSHS CP and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Software giant Microsoft Corp. said Thursday after the markets closed that its first quarter profit fell 13% from last year, hurt mainly by integration and restructuring costs even as revenue surged 25% thanks to strong sales of its gadgets and cloud-based products. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. After turning lower over the course of the previous session, stocks showed a substantial move back to the upside during trading on Thursday. The gains more than offset yesterday's loss, extending the recovery from the recent sell-off. Alaska Congressman Don Young, R-Ak., is once again making headlines with comments linking the state's high suicide rate to an increase in government assistance. Young told an audience at a senior center on Wednesday that the suicide problem didn't exist until there was "largesse" from the government.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.